Feedback PLC Digital Health article highlights Bleepa potential
03 August 2021 - 8:00AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
03 August 2021
RNS REACH
Feedback plc
Digital Health article highlights potential for Bleepa
-- Digital Health webinar explores the clinical and regulatory
risks of mobile messaging platforms
London, 03 August 2021: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
has been featured in an article in Digital Health.
The article raises legitimate concerns around security of mobile
messaging platforms and discusses the worries of those in the
industry wanting to use them. "Mobile messaging systems are a vital
tool to enable busy clinicians to manage heavy caseloads, but there
is increasing concern about the clinical and regulatory risk to
which some systems can expose users and their employers. A recent
Digital Health webina r explored this topic and found that more
than half of the 130 or so participants were concerned that the
messaging platform they used for clinical work did not comply with
GDPR. In addition, more than a third of participants were worried
that decisions made using their messaging system did not link to
their organisation's electronic patient record (EPR)."
For the full article, click here:
https://www.digitalhealth.net/2021/07/mobile-messaging-platforms-the-clinical-and-regulatory-risks-explored/
Dr Tom Oakley, CEO of Feedback, added: "We are delighted to have
been featured in Digital Health's article following an extremely
insightful webinar which discussed the significant exposure to risk
that Trusts and clinicians have when using unregulated devices and
the pitfalls that mobile messaging platform must navigate to
provide truly secure and safe systems for clinicians to use. We
understand that clinicians need a tool that allows them to complete
their work in a compliant and secure way. Bleepa is the forerunner
in providing exactly these needs and applaud Digital Health's focus
on the needs and safety of both clinicians and their patients
alike. "
Tom Oakley joined Digital Health's highly successful webinar
alongside Georges Ng Man Kwong, Consultant Chest Physician and
Chief Clinical Information Officer at Pennine Acute Hospitals NHS
Trust and Darryn Hale, Senior Associate, Beachcroft LLP, a
healthcare information governance legal specialist, to discuss
'Safe, secure and compliant clinical messaging: lessons from the
COVID-19 pandemic'.
For the Digital Health webinar highlights:
https://youtu.be/w8NzEHowUUo
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Vivek Bhardwaj +44 (0)20 3328 5656
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRADKBBKBBKDAFK
(END) Dow Jones Newswires
August 03, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024